Skip to main content

AI could enable accurate screening for atrial fibrillation

A new Mayo Clinic research study shows that artificial intelligence (AI) can detect the signs of an irregular heart rhythm -- atrial fibrillation (AF) -- in an electrocardiogram (EKG), even if the heart is in normal rhythm at the time of a test. In other words, the AI-enabled EKG can detect recent atrial fibrillation that occurred without symptoms or that is impending, potentially improving treatment options. This research could improve the efficiency of the EKG, a noninvasive and widely available method of heart disease screening. The findings and an accompanying commentary are published in The Lancet.
While common, atrial fibrillation often is fleeting. Therefore, it is challenging to diagnose. Atrial fibrillation may not occur during a standard 10-second, 12-lead EKG, and people are often unaware of its presence. Prolonged monitoring methods, such as a loop recorder, require a procedure and are expensive.
Accuracy and timeliness are important in making an atrial fibrillation diagnosis. Left undetected, atrial fibrillation can cause stroke, heart failure and other cardiovascular disease. Knowing that a patient has atrial fibrillation helps direct treatment with blood thinners, notes Paul Friedman, M.D., chair of the Department of Cardiovascular Medicine at Mayo Clinic. Dr. Friedman, who is a cardiac electrophysiologist, is the study's senior author.
"When people come in with a stroke, we really want to know if they had AF in the days before the stroke, because it guides the treatment," says Dr. Friedman. "Blood thinners are very effective for preventing another stroke in people with AF. But for those without AF, using blood thinners increases the risk of bleeding without substantial benefit. That's important knowledge. We want to know if a patient has AF."
Using approximately 450,000 EKGs of the over 7 million EKGs in the Mayo Clinic digital data vault, researchers trained AI to identify subtle differences in a normal EKG that would indicate changes in heart structure caused by atrial fibrillation. These changes are not detectable without the use of AI.
Researchers then tested the AI on normal-rhythm EKGs from a group of 36,280 patients, of whom 3,051 were known to have atrial fibrillation. The AI-enabled EKG correctly identified the subtle patterns of atrial fibrillation with 90% accuracy.
Dr. Friedman says that he is surprised by the findings of this research. If proven out, he said, AI-guided EKGs could direct the right treatment for disease caused by atrial fibrillation, even without symptoms. Moreover, this technology can be processed using a smartphone or watch, making it readily available on a large scale.
"An EKG will always show the heart's electrical activity at the time of the test, but this is like looking at the ocean now and being able to tell that there were big waves yesterday," says Dr. Friedman. "AI can provide powerful information about the invisible electrical signals that our bodies give off with each heartbeat -- signals that have been hidden in plain sight."
"Rather than finding the needle in the haystack by prolonged monitoring, authors basically suggest that AI will be able to judge by looking at the haystack if it has a needle hidden in it," notes Jeroen Hendriks, Ph.D., of the University of Adelaide in Australia, who wrote the study's commentary with Larissa Fabritz, M.D., of the University of Birmingham in the U.K.
Zachi I. Attia and Peter Noseworthy, M.D., are equal first authors of the study. Other authors are Francisco Lopez-Jimenez, M.D.; Samuel Asirvatham, M.D.; Abhishek Deshmukh, M.B.B.S.; Bernard Gersh, M.B., Ch.B., D.Phil.; Rickey Carter, Ph.D.; Xiaoxi Yao, Ph.D.; Alejandro Rabinstein, M.D.; Bradley Erickson, M.D., Ph.D.; and Suraj Kapa, M.D. -- all of Mayo Clinic.
Story Source:
Materials provided by Mayo Clinic. 
Note: Content may be edited.

Comments

Post a Comment

Popular posts from this blog

Size matters: New data reveals cell size sparks genome awakening in embryos

Transitions are a hallmark of life. When dormant plants flower in the spring or when a young adult strikes out on their own, there is a shift in control. Similarly, there is a transition during early development when an embryo undergoes biochemical changes, switching from being controlled by maternal molecules to being governed by its own genome. For the first time, a team from the Perelman School of Medicine at the University of Pennsylvania found in an embryo that activation of its genome does not happen all at once, instead it follows a specific pattern controlled primarily by the various sizes of its cells. The researchers published their results this week as the cover story in  Developmental Cell . In an early embryo undergoing cell division, maternally loaded RNA and proteins regulate the cell cycle. The genomes of the zygote -- a term for the fertilized egg -- are initially in sleep mode. However, at a point in the early life of the embryo, these zygotic nuclei "wake...
Post a Comment
Read more

Home births as safe as hospital births: International study suggests

A large international study led by McMaster University shows that low risk pregnant women who intend to give birth at home have no increased chance of the baby's perinatal or neonatal death compared to other low risk women who intend to give birth in a hospital. The results have been published by  The Lancet 's  EClinicalMedicine  journal. "More women in well-resourced countries are choosing birth at home, but concerns have persisted about their safety," said Eileen Hutton, professor emeritus of obstetrics and gynecology at McMaster, founding director of the McMaster Midwifery Research Centre and first author of the paper. "This research clearly demonstrates the risk is no different when the birth is intended to be at home or in hospital." The study examined the safety of place of birth by reporting on the risk of death at the time of birth or within the first four weeks, and found no clinically important or statistically different risk between home...
Post a Comment
Read more

Molecular adlayer produced by dissolving water-insoluble nanographene in water

Molecular adlayer produced by dissolving water-insoluble nanographene in water : "Nanographene incorporated micelle capsules" can be prepared by simply pulverizing and mixing nanographene with amphiphilic V-shaped anthracene molecules in water at room temperature. Even though nanographene is insoluble in water and organic solvents, Kumamoto University (KU) and Tokyo Institute of Technology (Tokyo Tech) researchers have found a way to dissolve it in water. Using "molecular containers" that encapsulate water-insoluble molecules, the researchers developed a formation procedure for a nanographene adlayer, a layer that chemically interacts with the underlying substance, by just mixing the molecular containers and nanographene together in water. The method is expected to be useful for the fabrication and analysis of next-generation functional nanomaterials. Graphene is a single layer of carbon atoms arranged in sheet form. It is lighter than metal wit...
Post a Comment
Read more